Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03297099
Other study ID # SWHZSG006
Secondary ID Zhengshuguo
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2017
Est. completion date June 1, 2020

Study information

Verified date July 2018
Source Southwest Hospital, China
Contact Shuguo Zheng
Phone 0086-13508308676
Email shuguozh@yahoo.com.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The indication of laparoscopic surgery is mainly for early regional type hepatolithiasis. Open surgery is the traditional treatment method for heptolithiasis. Da Vinci surgical robot can overcome limitations of conventional laparoscopic surgery in terms of vision and instrumentation flexibility, making the minimally invasive treatment of complex hepatolithiasis possible. The study aimed to evaluate the safety, feasibility, and efficacy of robot assist laparoscopic surgery for the treatment of complicated hepatolithiasis by contrast of open procedures.


Description:

Robot-assisted laparoscopic operation is a safe and feasible treatment for selected patients with complicated hepatolithiasis, with an advantage over open surgery in the field of intraoperative blood loss, less hilar occlusion, lower transfusion rate, less postoperative hospital stay.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date June 1, 2020
Est. primary completion date June 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

1. Patients with intrahepatic bile duct stones or hepatolithiasis.

2. Liver function > Child-pugh level B, no severe biliary cirrhosis, ICG = 15%, the residual liver volume and standard liver volume ratio = 40%. The conditions of open hepatectomy were achieved

3. Age: Between 18 to 70 years

4. Combined with severe liver atrophy hypertrophy syndrome, hepatic portal transposition or hilar biliary fibrosis / stenosis

5. Patients with good general condition, the conditions of open Anatomical Hepatectomy were achieved

6. Other organ lesions and previous biliary tract operation is not the absolute exclusion criteria

7. Written informed consent

Exclusion Criteria:

1. Patients with bad general condition or important organ lesions, liver resection could not be tolerated

2. Age:Younger than 18 or more than 70 years old

3. Malignant tumor recurrence within one month postoperation

4. Complicated case need to get emergency operation

5. Contraindication of laparoscopy: Combined with complicated acute cholangitis, repeated biliary tract operation, heavy intra-abdominal adhesion, Trocar can not be placed in. Artificial pneumoperitoneum could not be tolerated

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Robot-assisted Laparoscopic operation
Thirty patients with hepatolithiasis were selected and divided into robot group as described in the detailed description. Under general anesthesia, the patient was placed in a supine 30-degree reverse Trendelengburg position with both legs separating. The surgeon work on the console, and assist surgeon stand between legs. Operation began with division of liver ligaments, liver mobilization, followed by intrahepatic access to the Glissonian pedicle . A endoscopic stapler devices was used for Glissonian pedicle cutting and suture. Liver parenchyma was divided by harmonic scalpel combined with vascular stapler.
open surgery
surgery group as described in the detailed description.Open surgery was performed under general anesthesia with the patient in the supine position. Routinely, a reversed L-shape incision was performed. Operation began with division of liver ligaments, liver mobilization, followed by intrahepatic access to the Glissonian pedicle . A endoscopic stapler devices was used for Glissonian pedicle cutting and suture. Liver parenchyma was divided by harmonic scalpel combined with vascular stapler.

Locations

Country Name City State
China Southwest Hospital Chongqing Chongqing

Sponsors (1)

Lead Sponsor Collaborator
Southwest Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other postoperative complications ascites, pleural effusion,cardiopulmonary insufficiency,mortality, postoperative liver function failure. Duration hospitalization(an expected average of 7 days)
Primary initial stone clearance rate rate of the removal of the stones from intrahepatic bile duct identified by ultrasonic or computed tomography or magnetic resonance during the operation
Secondary intraoperative parameters operation time, intraoperative blood loss, rate of blood transfusion during the operation
See also
  Status Clinical Trial Phase
Recruiting NCT06130436 - Application of Perioperative Remote Ischemic Conditioning in Patients Undergoing Hepatectomy N/A
Recruiting NCT01459549 - Randomized Controlled Trial of Treating Hepatolithiasis (Accompanied With SOL) With Choledochojejunostomy N/A
Not yet recruiting NCT06447181 - Application of Three- Dimensional Visualization Combined With ICG Molecular Fluorescence Imaging in Hepatolithiasis
Recruiting NCT03958825 - Open Versus Laparoscopic Left Hepatic Sectionectomy N/A
Recruiting NCT03098264 - Safety and Efficacy of Simultaneous or Staged Surgery on Complicated Hepatolithiasis N/A
Recruiting NCT03098251 - Effect of 3D Typing on Surgical Treatment of Hepatolithiasis N/A